Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Oral Contraceptive Pills Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024


 

Available formats:    

StumbleUponEmail

Global Oral Contraceptive Pills Market

 

By Drug Type (Progestin Only Pills, Combination Pills, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global oral contraceptive pills market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Oral Contraceptive Pills Market

Oral contraceptive pills or birth control pills are the medications used to prevent the pregnancy. These are hormonal preparations that contain combination of hormones estrogen and progestin or progestin alone. The mechanism of action of oral contraceptive pills is prevent the pregnancy by inhibiting the follicle stimulating hormone (FSH) and Luteinizing hormone (LH) which play a major roles in egg development and preparation of lining of uterus for implantation of embryo.

 

Market Dynamics: Oral Contraceptive Pills Market

Increase in the incidence of unwanted pregnancies is anticipated to drive the global oral contraceptive pills market. Moreover, rise in female population, low cost of oral contraceptive pills, ease of administration, adoption of novel oral contraceptive pills in developed and developing countries, and high effectiveness of the pills are anticipated to propel the global oral contraceptives market. However, stringent regulatory guidelines for the oral contraceptive pills usage, adverse effects associated with the products, religious issues, and poor availability of the products in underdeveloped regions are major restrains of global oral contraceptive pills market over the forecast years.

 

Market Scope: Oral Contraceptive Pills Market

Oral Contraceptive Pills market is segmented based on the drug type, and distribution channel

Based on the drug type, the market is segmented into the following:

  • Progestin Only Pills
  • Combination Pills
  • Monophasic
  • Triphasic
  • Others
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

 

Regional Analysis:  Oral Contraceptive Pills Market

Geographically, global oral contraceptive pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America oral contraceptive pills market has a lucrative share attributed to high incidence rate of unwanted pregnancies, government support to opt for modern oral contraceptive pills and rise in disposable income. Europe oral contraceptive pills market is poised to grow due to expansion of business by the market players in EU region, grow in women workforce preferring to postpone the pregnancies, and better availability of the products are expected to bolster the market. Asia Pacific oral contraceptive pills market has a lucrative growth attributed to surge in awareness about the family planning and oral contraceptive pills, rise in disposable income, and increase in people opting for right decisions about their sexual and reproductive health are enhance the revenue of market .

 

Competition Assessment: Oral Contraceptive Pills Market

Some of the players in the global oral contraceptive pills market include:

  • Actavis plc (Allergan plc) (Ireland)
  • Bayer AG (Germany)
  • Merck & Co. Inc. (U.S.)
  • Pfizer, Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Church & Dwight Co, Inc. (U.S)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Piramal Enterprises Limited (India)

 

Notable Market Developments: Oral Contraceptive Pills Market

  • In April 2018, Mylan N.V. launched Drospirenone and Ethinyl Estradiol tablets in U.S. used as oral contraceptive pills.

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • Actavis plc (Allergan plc) (Ireland)
  • Bayer AG (Germany)
  • Merck & Co. Inc. (U.S.)
  • Pfizer, Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Church & Dwight Co, Inc. (U.S)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Piramal Enterprises Limited (India)
  1. Executive Summary

 

  1. Global Oral Contraceptive Pills Market Introduction
    • Global Oral Contraceptive Pills Market – Taxonomy
    • Global Oral Contraceptive Pills Market –Definitions
      • Drug Type
      • Distribution Channel

 

  1. Global Oral Contraceptive Pills Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Oral Contraceptive Pills Market Dynamic Factors – Impact Analysis
    • Global Oral Contraceptive Pills Market – Competition Landscape
    • Epidemiology

 

  1. Global Oral Contraceptive Pills Market Analysis,2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis

 

  1. Global Oral Contraceptive Pills Market, By Drug Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Progestin Only Pills
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Combination Pills
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Monophasic
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Triphasic
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis

 

  1. Global Oral Contraceptive Pills Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis

 

  1. Global Oral Contraceptive Pills Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Oral Contraceptive Pills Market – Opportunity Analysis Index, By Drug Type, By Distribution Channel and Region, 2018 – 2024

 

  1. North America Oral Contraceptive Pills MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Progestin Only Pills
      • Combination Pills
      • Monophasic
      • Triphasic
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Oral Contraceptive Pills Market – Opportunity Analysis Index, By Drug Type, By Distribution Channel and Country, 2018 – 2024
    • North America Oral Contraceptive Pills Market Dynamics – Trends

 

  1. Europe Oral Contraceptive Pills Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Progestin Only Pills
      • Combination Pills
      • Monophasic
      • Triphasic
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Oral Contraceptive Pills Market – Opportunity Analysis Index, By Drug Type, By Distribution Channel and Country, 2018 – 2024
    • Europe Oral Contraceptive Pills Market Dynamics – Trends

 

  1. Asia-Pacific Oral Contraceptive Pills Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Progestin Only Pills
      • Combination Pills
      • Monophasic
      • Triphasic
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Oral Contraceptive Pills Market – Opportunity Analysis Index, By Drug Type, By Distribution Channel and Country, 2018 – 2024
    • Asia-Pacific Oral Contraceptive Pills Market Dynamics – Trends

 

  1. Latin America Oral Contraceptive Pills Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Progestin Only Pills
      • Combination Pills
      • Monophasic
      • Triphasic
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Oral Contraceptive Pills Market – Opportunity Analysis Index, By Drug Type, By Distribution Channel and Country, 2018 – 2024
    • Latin America Oral Contraceptive Pills Market Dynamics – Trends

 

  1. Middle East and Africa Oral Contraceptive Pills Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Drug Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Progestin Only Pills
      • Combination Pills
      • Monophasic
      • Triphasic
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Oral Contraceptive Pills Market – Opportunity Analysis Index, By Drug Type, By Distribution Channel and Country, 2018 – 2024
    • MEA Oral Contraceptive Pills Market Dynamics – Trends

 

  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Actavis plc (Allergan plc) (Ireland)
      • Bayer AG (Germany)
      • Merck & Co. Inc. (U.S.)
      • Pfizer, Inc. (U.S.)
      • Teva Pharmaceutical Industries Ltd (Israel)
      • Church & Dwight Co, Inc. (U.S)
      • Mylan N.V. (U.S.)
      • Novartis AG (Switzerland)
      • Piramal Enterprises Limited (India)

 

  1. Research Methodology
  2. Key Assumptions and Acronyms

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553